Pharma News: CPhI SEA Opening In 5 weeks - Who Are the Machinery Exhibitors?

JAKARTA, Indonesia, Feb. 15, 2017 /PRNewswire/ -- In 5 weeks' time, CPhI SEA  is set to open its doors from March 22-24 at Jakarta International Expo, offering the only dedicated pharma trading platform for the region. Sign up today ! ...

2017-02-15 10:00 1887

Janssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Maintaining Viral Suppression in Phase III Clinical Studies

SEATTLE, Feb. 14, 2017 /PRNewswire/ -- - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression   Janssen Sciences Ireland UC ...

2017-02-14 19:19 1486

Kungl. Vetenskapsakademien - The First Sjoberg Prize, Totalling 1 Million US Dollars, is Awarded for Discoveries That Have Led to New and Effective Cancer Treatments

BOX, Sweden, Feb. 14, 2017 /PRNewswire/ -- The Royal Swedish Academy of Sciences has decided to award the Sjoberg Prize 2017 toJames P. Allison, The University of Texas MD Anderson Cancer Center, Houston, TX, USA and Tony Hunter, Salk Institute for Biological Studies, La Jolla, CA, USA "for grou...

2017-02-14 14:15 1471

Finesse(R) Solutions Announces CellWorld Shanghai 2017 Executive Forum

SANTA CLARA, California, Feb. 14, 2017 /PRNewswire/ -- Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announces the fourth CellWorld Shanghai Conference, an event specifically designed for innovators, visionaries and senior exe...

2017-02-14 10:01 2198

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

INDIANAPOLIS, Feb. 14, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for Olumiant® (baricitinib) 4 mg and 2 mg film-coated tablets inEurope for the treatment of moderate...

2017-02-14 06:27 2031

Hearing Date of Thalidomide Lawsuit in Germany Announced

COLOGNE, Germany, Feb. 13, 2017 /PRNewswire/ -- 60 years after the market launch of Contergan (active ingredient: thalidomide), the greatest pharmaceutical scandal in the Federal Republic ofGermany continues to boil. A lawsuit will be heard in the Bonn Regional Court at 12:00 hrs on15.2.2017 that...

2017-02-13 09:00 2790

Infinitus Recognized by European Authority for Quality Innovation

PRAGUE, Feb. 10, 2017 /PRNewswire/ -- At the 2016 Quality Innovation Award ceremony recently held inPrague, Czech, six Chinese companies including Infinitus (China) Company Ltd., a member of LKK Health Products Group (LKKHPG), won six awards for their six projects, including one first prize and f...

2017-02-10 17:22 3471

Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry

SANTA CLARA, Calif., Feb. 9, 2017 /PRNewswire/ -- A confluence of innovative technologies moving from concept to reality correlated with macroeconomic factors such as cost of care constraints, consumerism, and connectivity are leading to a replacement of outdated models of care withprecision medi...

2017-02-09 21:36 2591

Pharma Exhibitors At CPhI South East Asia Use Event To Expand Sales Regionally

JAKARTA, Indonesia, Feb. 9, 2017 /PRNewswire/ -- CPhI South East Asia returns to the Jakarta International Expo in Indonesia for its fifth edition from 22nd-24th March 2017 as regional pharma companies expect robust growth. In fact, the slowing pace of global markets an...

2017-02-09 19:03 2762

Hi China -- The Right Ingredients for Success

SHANGHAI, Feb. 6, 2017 /PRNewswire/ -- Health ingredients China (Hi China), organized by Shanghai UBM Sinoexpo International Exhibition Co., Ltd., will take place from June 20-22 at the Shanghai New International Expo Centre (SNIEC) in Shanghai.

2017-02-06 09:00 1791

World First Breast Cancer Prevention Trial

ADELAIDE, Australia, Feb. 3, 2017 /PRNewswire/ -- Well-known Breast Cancer Specialist, DrStephen Birrell of Wellend Health at Burnside Hospital, in partnership with U.S. based breast cancer pharmaceutical company HAVAH Therapeutics Inc., announced the recruitment of the first women to receive a ...

2017-02-03 06:43 3082

Pharma News: CPhI SEA -- Who Are the New Exhibitors?

JAKARTA, Indonesia, Feb. 2, 2017 /PRNewswire/ -- In less than 2 months' time, CPhI SEA  is set to open its doors from March 22-24 at Jakarta International Expo, offering the only dedicated pharma trading platform for the region. Sign up today

2017-02-02 19:33 3212

Rentschler and Leukocare Announce Strategic Alliance and Equity Investment

LAUPHEIM and MUNICH, Germany, Feb. 2, 2017 /PRNewswire/ -- Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler's  bio...

2017-02-02 16:00 3610

Health Ingredients in South East Asia: Sign Up for Fast Growing Opportunities

JAKARTA, Indonesia, Feb. 2, 2017 /PRNewswire/ -- In less than 2 months' time,  Hi SEA  / CPhI  is set to open its doors from March 22-24 at Jakarta International Expo, offering a dedicated health and pharma ingredients trading pl...

2017-02-02 15:25 2691

Flexible Storage Options can Impact Daily Use of FVIII Treatments in People with Haemophilia A

PARIS, Feb. 1, 2017 /PRNewswire/ -- This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied D...

2017-02-01 15:00 2142

Kaneka North America, LLC To Increase The Off List Selling Price For Kane Ace® Specialty Additives

PASADENA, Texas, Jan. 31, 2017 /PRNewswire/ -- Due to recent significant increases of key raw materials,Kaneka North America, LLC will increase the off list selling price for Kane Ace® specialty additives per the following schedule Feb.1, 2017 or as Contracts or Agreements allow: PRODUCT  Feb. ...

2017-01-31 01:43 2926

NeuroVive Redirects Research Resources From Asian Subsidiary to Parent

Lund, Sweden, Jan 25, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that itsTaiwan-based subsidiary's research resources and activities will be redirected to the parent company NeuroVive Pharmaceutical ...

2017-01-25 16:09 2028

NeuroVive Signs Mitochondrial Medicine Research Agreement With US key Opinion Leader

LUND, Sweden, Jan. 23, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF),today announces that NeuroVive has signed a preclinical collaboration agreement with the Children's Hospital ofPhiladelphia (CHOP) andMarni J. Falk, M.D., a US key opinion leader in the m...

2017-01-23 16:03 2057

CPhI SEA -- the leading pharma event in South East Asia - adds 6 new features

JAKARTA, Indonesia, Jan. 18, 2017 /PRNewswire/ -- With an annual growth ranging from 6% to 10%,South East Asia's pharma industry is poised for success. CPhI SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the regional discourse ...

2017-01-18 09:00 2398

CPhI: Pharma in South East Asia wins through Innovation, M&A, JVs and strategic Partnerships to spur Markets Integration

JAKARTA, Jan. 13, 2017 /PRNewswire/ -- Over the last 10 years South East Asia (SEA) pharmaceutical markets have been developing rapidly (6% – 10% yoy) and are expected to deliver remarkable future growth.Indonesia is the largest market in the region, followed byThailand, the Philippines, Vietnam,...

2017-01-13 17:52 2368
1 ... 9899100101102103104 ... 132